Propofol
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Propofol is an early-stage landscape with 2 programs across 6 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Fresenius Kabi Oncology Ltd., Haisco Pharmaceutical Group Co., Ltd.. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
1 program
Fresenius Kabi Oncology Ltd.
1 program
Haisco Pharmaceutical Group Co., Ltd.
0 programs
Eisai
0 programs
Jiangsu Nhwa Pharmaceutical Co., Ltd.
0 programs
Fresenius
0 programs
Pipeline
Programs by Phase
Analysis
Trial Status
63
clinical trials
Clinical Trials
Trial Activity
63 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)